1. Home
  2. POCI vs PMN Comparison

POCI vs PMN Comparison

Compare POCI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

HOLD

Current Price

$5.17

Market Cap

32.6M

Sector

Health Care

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$9.61

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POCI
PMN
Founded
1982
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.6M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
POCI
PMN
Price
$5.17
$9.61
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
15.1K
16.1K
Earning Date
02-12-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,575,039.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.67
N/A
52 Week Low
$3.77
$6.27
52 Week High
$5.34
$39.75

Technical Indicators

Market Signals
Indicator
POCI
PMN
Relative Strength Index (RSI) 78.52 77.52
Support Level $4.27 $8.08
Resistance Level $5.28 $8.51
Average True Range (ATR) 0.20 0.51
MACD 0.10 0.03
Stochastic Oscillator 80.49 100.00

Price Performance

Historical Comparison
POCI
PMN

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: